Perfil clínico-epidemiológico de idosos submetidos à quimioterapia antineoplásica atendidos em um hospital de referência oncológica do estado do Pará, Brasil

Emerson Glauber Abreu dos Santos; Jessika Cardoso de Souza; Anderson Lineu Siqueira dos Santos; Maria Izabel Penha de Oliveira Santos; Tatyellen Natasha da Costa Oliveira

doi:10.5123/S2176-62232017000200006

Authors

Emerson Glauber Abreu dos Santos Universidade Federal do Pará, Belém, Pará, Brasil
Jessika Cardoso de Souza Fundação Hospital de Clínicas Gaspar Vianna, Belém, Pará, Brasil. Universidade do Estado do Pará, Belém, Pará, Brasil
Anderson Lineu Siqueira dos Santos Universidade do Estado do Pará, Belém, Pará, Brasil
Maria Izabel Penha de Oliveira Santos Universidade do Estado do Pará, Belém, Pará, Brasil
Tatyellen Natasha da Costa Oliveira Universidade do Estado do Pará, Belém, Pará, Brasil. Instituto Evandro Chagas/SVS/MS, Ananindeua, Pará, Brasil

DOI:

https://doi.org/10.5123/S2176-62232017000200006

Keywords:

Elderly, Drug Therapy, Health Profile, Medical Oncology, Antineoplastic Agents

Abstract

OBJECTIVE:

To describe the clinical and epidemiological profile of elderly patients undergoing anti-neoplasic chemotherapy treatment, as outpatients of a reference hospital of Pará State, Brazil.

MATERIALS AND METHODS:

A cross-sectional study involving 200 elderly people was performed from April to October, 2015. A socioeconomic and clinical questionnaire was applied and statistical analyses were done afterwards.

RESULTS:

The prevalence was 60-80 years old (83.5%); no gender predominance; low schooling - 82.5% of the participants had finished the elementary school; low family income, from them 79.5% had a family income less than three minimum wages, and 87.5% participating actively in family income; and 57.0% were married or were in stable union. The most common cancer type was breast cancer (26.5%), followed by prostate cancer (17.0%); and the most prevalent anti-neoplasic or adjuvant treatments were bisphosphonate and alkylating agent.

CONCLUSION:

This study demonstrated the elderly patients profile receiving anti-neoplasic treatment at an oncological reference unit in the North of Brazil, predominating individuals with other comorbidities besides neoplasm, which increases the risks of complications and adverse reactions related to the chemotherapy.